CRISPR Therapeutics AG (CRSP) came out with a quarterly loss of $1.28 per share versus the Zacks Consensus Estimate of a loss of $1.14. This compares to a loss of $1.58 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -12.39%. A quarter ago, it was expected that this company would post a loss of $1.15 per share when it actually produced a loss of $1.37, delivering a surprise of -19.13%.Over the last four quarters, the company h ...